IDDI - Data With Purpose

See What Others Don't in Ophthalmology Clinical Trials

IDDI Offers the Highest Standard in Ophthalmology-Focused Clinical Data Science

52% of patients who enter screening in retina trials fail to qualify.1

Ophthalmic imaging endpoints often lose almost 40% of scans to quality issues.2

Common functional endpoints have up to 50% variability.3

Ophthalmology clinical trials seem straightforward, until hidden pitfalls start impacting your data quality, timeline, and budget.

What Are the Most Common Ophthalmology Clinical Trial Challenges?

From enrollment and endpoint selection to regulatory expectations, ophthalmology trials face unique difficulties:

  • Flawed trial designs delay timelines and waste resources
  • Misaligned endpoints increase risk of failure or rejection
  • Siloed teams cause inefficiencies and costly errors
  • Poor recruitment plans risk delays and underpowered studies
  • Ignored variables lead to flawed analysis and failed trials

A surface-level approach isn't enough. To avoid costly missteps, unlock efficiencies, and pave the way for more effective ophthalmology treatments, see what others don't with IDDI.

The Benefits of a Biostatistics-First Model

With a 35+ year legacy and experience supporting 180+ ophthalmology trials across retinal diseases, glaucoma, rare diseases, and MedTech, IDDI is your clinical data partner.

Our biostatistics-first model is the key to successful ophthalmology clinical trials, going deeper with strategic design, superior execution, therapeutic expertise, and a laser focus on helping patients to reduce risk and improve outcomes.

References

  1. Hasan, N., Mehrotra, K., Danzig, C., et al. Screen Failures in Clinical Trials in Retina. Ophthalmology Retina. November 2024.
  2. Lujan, B.J., Calhoun, C.T., Glassman, A.R., et al. Optical Coherence Tomography Angiography Quality Across Three Multicenter Clinical Studies of Diabetic Retinopathy. Transl Vis Sci Technol. March 2021.
  3. Rabiolo, A., Morales, E., Afifi, A., et al. Quantification of Visual Field Variability in Glaucoma: Implications for Visual Field Prediction and Modeling. TVST. October 2019.

Download the One-Pager to See What Others Don't

Our one-pager takes a closer look at ophthalmology clinical trial challenges and IDDI's biostatistics-driven solutions, giving you an exclusive view of what it takes to win in this growing therapeutic area. Get your copy now to see what others don't.

By submitting this form, you agree to receiving commercial electronic messages such as e-mails from IDDI. For more info, please visit our Privacy Policy. You can unsubscribe at any time by clicking the 'unsubscribe' button at the foot of any e-mail communication from IDDI.